PAX8 and thyroid gland carcinoma: Alterations of PPARG have been discovered in a large number of thyroid cancer samples, such as PAX8/PPARG fusion oncogene in follicular thyroid carcinoma and PTCs [34]–[37], and another PPARG agonist (RS54444) in ATCs [38].